Mobile

Evaluation of the pharmacodynamic effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction in a randomized, double blind, placebo controlled, par...

Mise à jour : Il y a 5 ans
Référence : EUCTR2014-003055-60

Evaluation of the pharmacodynamic effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction in a randomized, double blind, placebo controlled, parallel group, multicenter study Pharmakodynamische Effekte des Medikaments Riociguat (Adempas®) bei Patienten mit Lungenhochdruck in Verbindung mit einer Herzinsuffizienz und erhaltener Linksventrikelfunktion – eine randomisierte, doppelblinde, Placebo kontrollierte, multizentrische Parallellgruppen-Studie

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to - Assess the pharmacodynamic profile of riociguat in subjects with symptomatic pulmonary hypertension and heart failure with preserved ejection fraction

Critère d'inclusion

  • Pulmonary hypertension and heart failure with preserved ejection fraction

Liens